RxSight, Inc. announced that Dr. Dan Tran and his team have completed 1,000 Light Adjustable Lens® (LAL) implants for Coastal Vision Medical Group.
Public source
Publisher name
Public post
Dr. Dan Tran and his team are celebrating a new milestone: 1,000 Light Adjustable Lens® (LAL) implants! For more than 25 years, Coastal Vision Medical Group has led adva…
Company
RxSight, Inc.
RxSight makes the Light Adjustable Lens™ (LAL®)—the only FDA-approved lens you can adjust after cataract surgery.
- Industry
- Medical Equipment Manufacturing
- Location
- Aliso Viejo, US
- Company size
- 201–500 employees
About RxSight, Inc.
RxSight is a medical device company dedicated to transforming cataract surgery outcomes through the power of adjustability. The company makes the Light Adjustable Lens™ (LAL®), the only FDA-approved intraocular lens (IOL) that can be customized after cataract surgery using ultraviolet (UV) light treatments. Unlike traditional IOLs—which are fixed at the time of implantation—the LAL allows the treating physician to fine-tune the lens prescription after the eye has fully healed. This means patients receive a vision outcome tailored to their actual, post-surgical visual needs rather than a pre-surgical estimate. RxSight (Nasdaq: RXST) works with cataract surgeons and ophthalmologists to bring this personalized approach to vision care. For physicians, the LAL platform provides a clinical differentiation that no other premium IOL can match.
See moreLatest activity
Latest activity from RxSight, Inc.
6 signals
Partnerships
RxSight, Inc. is working with Dagny Zhu, M.D. and Angela Vuong in a new partnership with Laser Eye Center of Silicon Valley.
Presence & Recognition
RxSight, Inc. showcased newly accepted research exploring the potential of the Light Adjustable Lens™ across a range of patient types at ESCRS2026
Products & Services
RxSight, Inc. completed the 250th Light Adjustable Lens™ (LAL) procedure for cataract patients at Gulf Coast Eye Institute in the Rio Grande Valley, Texas.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
EyeOn
EyeOn announced that Dr. Orlando González at VISTA used miLOOP for complete nucleus fragmentation in under 30 seconds during cataract surgery.
Products & Services
Avisi Technologies
Avisi Technologies successfully completed the first implantation of the VisiPlate Aqueous Shunt at the University of Pennsylvania following a successful surgical procedure performed by the surgical team at Scheie Eye Institute.
Products & Services
BVI Medical
BVI Medical introduced ISOPURE SERENITY, a non-difractive optical design for cataract surgery that supports straightforward patient counselling and handles, implantation, and surgical technique as familiar as a conventional monofocal IOL.
Products & Services
OCULUS Surgical
OCULUS Surgical launched the OCULUS BIOM® 6, a closed optical design motorized head-up system designed for precision, safety, and efficiency.
Products & Services
Topcon Healthcare